ClinVar Genomic variation as it relates to human health
NM_001384140.1(PCDH15):c.3667_3668del (p.Ile1223fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001384140.1(PCDH15):c.3667_3668del (p.Ile1223fs)
Variation ID: 1027565 Accession: VCV001027565.1
- Type and length
-
Deletion, 2 bp
- Location
-
Cytogenetic: 10q21.1 10: 53866691-53866692 (GRCh38) [ NCBI UCSC ] 10: 55626451-55626452 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 19, 2021 Mar 19, 2021 Oct 1, 2020 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001384140.1:c.3667_3668del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001371069.1:p.Ile1223fs frameshift NM_033056.4:c.3667_3668del MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_149045.3:p.Ile1223fs frameshift NM_033056.4:c.3667_3668delAT MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_001142763.2:c.3682_3683del NP_001136235.1:p.Ile1228fs frameshift NM_001142764.2:c.3667_3668del NP_001136236.1:p.Ile1223fs frameshift NM_001142765.2:c.3454_3455del NP_001136237.1:p.Ile1152fs frameshift NM_001142766.2:c.3667_3668del NP_001136238.1:p.Ile1223fs frameshift NM_001142767.2:c.3556_3557del NP_001136239.1:p.Ile1186fs frameshift NM_001142768.2:c.3601_3602del NP_001136240.1:p.Ile1201fs frameshift NM_001142769.3:c.3703_3704del NP_001136241.1:p.Ile1235fs frameshift NM_001142770.3:c.3667_3668del NP_001136242.1:p.Ile1223fs frameshift NM_001142771.2:c.3682_3683del NP_001136243.1:p.Ile1228fs frameshift NM_001142772.2:c.3667_3668del NP_001136244.1:p.Ile1223fs frameshift NM_001142773.2:c.3601_3602del NP_001136245.1:p.Ile1201fs frameshift NM_001354404.2:c.3601_3602del NP_001341333.1:p.Ile1201fs frameshift NM_001354411.2:c.3688_3689del NP_001341340.1:p.Ile1230fs frameshift NM_001354420.2:c.3667_3668del NP_001341349.1:p.Ile1223fs frameshift NM_001354429.2:c.3667_3668del NP_001341358.1:p.Ile1223fs frameshift NC_000010.11:g.53866692_53866693del NC_000010.10:g.55626452_55626453del NG_009191.3:g.1767491_1767492del - Protein change
- I1152fs, I1186fs, I1201fs, I1223fs, I1228fs, I1230fs, I1235fs
- Other names
- -
- Canonical SPDI
- NC_000010.11:53866690:ATA:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
PCDH15 | - | - |
GRCh38 GRCh37 |
3395 | 3485 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
no assertion criteria provided
|
Oct 1, 2020 | RCV001328030.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Oct 01, 2020)
|
no assertion criteria provided
Method: research
|
Autosomal recessive nonsyndromic hearing loss 23
Usher syndrome type 1D Usher syndrome type 1F
This variant is in the PCDH15 gene
(more...)
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline,
paternal
|
National Institute on Deafness and Communication Disorders, National Institutes of Health
Accession: SCV001519363.1
First in ClinVar: Mar 19, 2021 Last updated: Mar 19, 2021
Comment:
was found associated in trans with NM_033056.4:c.1737C>G
|
Observation 1:
Clinical Features:
Profound childhood hearing loss (present)
Family history: yes
Age: 10-19 years
Sex: male
Ethnicity/Population group: African,Yoruba
Geographic origin: Nigeria;Ibadan
Segregation observed: yes
Secondary finding: no
Method: Verified by Sanger sequencing
Observation 2:
Clinical Features:
Profound childhood hearing loss (present)
Family history: yes
Age: 10-19 years
Sex: male
Ethnicity/Population group: African,Yoruba
Geographic origin: Nigeria;Ibadan
Segregation observed: yes
Secondary finding: no
Method: Verified by Sanger sequencing
Observation 3:
Clinical Features:
Profound childhood hearing loss (present)
Family history: yes
Age: 0-9 years
Sex: female
Ethnicity/Population group: African,Yoruba
Geographic origin: Nigeria;Ibadan
Segregation observed: yes
Secondary finding: no
Method: Verified by Sanger sequencing
Observation 4:
Clinical Features:
Profound childhood hearing loss (present)
Family history: yes
Age: 0-9 years
Sex: female
Ethnicity/Population group: African,Yoruba
Geographic origin: Nigeria;Ibadan
Segregation observed: yes
Secondary finding: no
Method: Verified by Sanger sequencing
Observation 5:
Clinical Features:
Profound childhood hearing loss (present)
Family history: yes
Age: 0-9 years
Sex: female
Ethnicity/Population group: African,Yoruba
Geographic origin: Nigeria;Ibadan
Segregation observed: yes
Secondary finding: no
Method: Verified by Sanger sequencing
Observation 6:
Clinical Features:
Profound childhood hearing loss (present)
Family history: yes
Age: 0-9 years
Sex: female
Ethnicity/Population group: African,Yoruba
Geographic origin: Nigeria;Ibadan
Segregation observed: yes
Secondary finding: no
Method: Verified by Sanger sequencing
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for rs2079481708 ...
HelpRecord last updated May 08, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.